HHS Uncovers $50M Insurance Fraud in Child Gender Procedures

The explosive 64-page document, titled “Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of ‘Gender Medicine,'” details allegations that physicians and hospital networks systematically misused medical billing codes to secure coverage from private insurers and Medicaid for puberty blockers, cross-sex hormones, and surgical interventions on children, according to Gabrielle M. Etzel writing in Washington Examiner.

The investigation identified more than 225 hospitals and health systems that opened pediatric gender clinics across the United States between 2015 and 2025. Following the fraud findings outlined in the report, the White House Task Force to Eliminate Fraud has referred these facilities to the Department of Justice and the HHS Office of Inspector General for potential violations of federal law.

Robert F. Kennedy, Jr., Secretary of Health and Human Services, emphasized the gravity of the findings. Doctors and hospitals must put children’s health ahead of ideology and financial gain, he stated in an official press release, adding that the department will follow the evidence and hold accountable anyone who violated the law or betrayed patient and family trust.

Fraudulent Billing Practices Alleged

The report alleges that pediatric gender clinics employed misleading or potentially fraudulent diagnostic and procedural codes to obtain insurance authorization for transgender medical treatments in minors. These treatments included major surgical procedures such as mastectomy and vaginoplasty.

Investigators documented a dramatic increase in the use of two specific diagnostic codes between 2015 and 2025: “endocrine disorder, unspecified” and “precocious puberty,” a rare medical condition that triggers the onset of puberty before age 8.

While puberty blockers represent appropriate treatment for genuine cases of precocious puberty, the report demonstrates that gender medicine clinics nationwide applied this diagnosis to patients aged 13 to 17, a clear indicator of potential insurance fraud.

$42.6 Million in Questionable Claims

Over the past decade, medical providers used the diagnostic code “endocrine disorder, unspecified” to prescribe puberty blockers to 239 patients, generating nearly $42.6 million in insurance claims. The report suggests many of these prescriptions were actually used to treat gender dysphoria rather than legitimate endocrine disease.

Commercial insurance paid the majority of these claims, but taxpayers also bore a significant burden through Medicaid, which covered nearly $7.8 million for the low-income families and children enrolled in the public insurance program.

Financial Incentives Behind Clinic Proliferation

The authors argue that the typically low revenue generated by pediatrics departments created strong financial incentives for hospitals to establish youth gender medicine clinics, which effectively create lifelong dependent patients.

Guidelines from the World Professional Association of Transgender Health recommend patients on hormone therapies receive blood work checks every three to six months, along with annual bone density scans and multidisciplinary team assessments continuing into adulthood.

Each of these steps represents billable encounters, prescriptions, and facility fees that generate ongoing revenue for hospitals and physician groups. The report’s authors note that these clinics promised a continuous revenue stream for pediatrics, endocrinology, and surgical specialties by taking physiologically healthy young people who would not otherwise require medical attention and rendering them medically dependent for life.

Report Authorship and Expected Pushback

The document is expected to face opposition from mainstream medical organizations that support transgender medical interventions for minors, partly due to its authorship. The report was written by several members of the Independent Women’s Forum, a women’s rights organization that opposes transgender medicine for minors, along with two researchers from the Ethics and Public Policy Center, a Christian policy organization that also opposes youth gender medicine.

Dr. Eithan Haim, who disclosed patient records from gender medicine treatments at Texas Children’s Hospital in Houston as a whistleblower, co-authored the report. Dr. Quentin Van Meter, a pediatric endocrinologist who has been vocal in his opposition to transgender procedures for minors, also contributed to the document.

An HHS spokesperson defended the authors’ credentials when questioned about their professional backgrounds, noting their decades of clinical practice, academic appointments, extensive publications, and legislative testimony.

With information from Washington Examiner